Search research articles
Contact Us
Filters
Showing results (1-10 of 109) with videos related to
Page
of 11
Sort By:
Cancer Journal (Sudbury, Mass.)
|
January 23, 2013
The changing natural history of metastatic prostate cancer
Ajjai Alva, Maha Hussain
Drugs
|
August 21, 2013
Optimal pharmacotherapeutic management of hormone-sensitive metastatic prostate cancer
Ajjai Alva, Maha Hussain
Current Treatment Options in Oncology
|
January 8, 2014
Intermittent androgen deprivation therapy in advanced prostate cancer
Ajjai Alva, Maha Hussain
Cancer Journal (Sudbury, Mass.)
|
January 22, 2014
Current and proposed molecular diagnostics in a genitourinary service line laboratory at a tertiary clinical institution
Aaron M Udager, Ajjai Alva, Rohit Mehra
Investigational New Drugs
|
December 10, 2013
Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
Ajjai Alva, Stephanie Daignault, David C Smith, et al.
Urology Case Reports
|
January 22, 2016
Urothelial Cancer With Occult Bone Marrow Metastases and Isolated Thrombocytopenia
Ajjai Alva, Elizabeth Davis, Arul M Chinnaiyan, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2018
Ipilimumab induced digital vasculitis
Amrita Padda, Elena Schiopu, Justin Sovich, et al.
AJR. American Journal of Roentgenology
|
March 1, 2018
Utility of Pelvic CT for Surveillance of T2-T4 Renal Cell Carcinoma After Nephrectomy With Curative Intent
Andrew Kaiser, Matthew S Davenport, Khaled S Hafez, et al.
Science Immunology
|
March 3, 2023
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, et al.
Science (New York, N.Y.)
|
May 8, 2004
Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8
Li Yu, Ajjai Alva, Helen Su, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 109) with videos related to
Sort By:
Page
of 11
Cancer Journal (Sudbury, Mass.)
|
January 23, 2013
The changing natural history of metastatic prostate cancer
Ajjai Alva, Maha Hussain
Drugs
|
August 21, 2013
Optimal pharmacotherapeutic management of hormone-sensitive metastatic prostate cancer
Ajjai Alva, Maha Hussain
Current Treatment Options in Oncology
|
January 8, 2014
Intermittent androgen deprivation therapy in advanced prostate cancer
Ajjai Alva, Maha Hussain
Cancer Journal (Sudbury, Mass.)
|
January 22, 2014
Current and proposed molecular diagnostics in a genitourinary service line laboratory at a tertiary clinical institution
Aaron M Udager, Ajjai Alva, Rohit Mehra
Investigational New Drugs
|
December 10, 2013
Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
Ajjai Alva, Stephanie Daignault, David C Smith, et al.
Urology Case Reports
|
January 22, 2016
Urothelial Cancer With Occult Bone Marrow Metastases and Isolated Thrombocytopenia
Ajjai Alva, Elizabeth Davis, Arul M Chinnaiyan, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2018
Ipilimumab induced digital vasculitis
Amrita Padda, Elena Schiopu, Justin Sovich, et al.
AJR. American Journal of Roentgenology
|
March 1, 2018
Utility of Pelvic CT for Surveillance of T2-T4 Renal Cell Carcinoma After Nephrectomy With Curative Intent
Andrew Kaiser, Matthew S Davenport, Khaled S Hafez, et al.
Science Immunology
|
March 3, 2023
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, et al.
Science (New York, N.Y.)
|
May 8, 2004
Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8
Li Yu, Ajjai Alva, Helen Su, et al.
Page
of 11